ライフサイエンスコーパス: avid

1 ging, as lymphomas are 18-fluorodeoxyglucose avid.

2 cellular carcinoma (HCC) that is not 18F-FDG-avid.

3 ly large lesions (19.5%) remained [(18)F]FDG avid.

4 n the ferrous deoxygenated state, and oxygen-avid.

5 escribe a new global alignment method called AVID.

6 47S isoprotein is predicted to be less lipid avid.

7 nchyma, or chest wall and were all (18)F-FDG avid.

8 anced breast cancers were (18)F-fluciclovine-avid.

9 PET/CT, as the metastases were not (18)F-FDG-avid.

10 etecting coronary plaque has been limited by avid (18)F-FDG uptake by the myocardium.

11 nd neck and esophageal carcinoma demonstrate avid (18)F-FDG uptake.

12 asmic enzymes in gram-negative bacteria with avid ability for beta-lactam turnover.

13 ifying enzymes and genotypes conferring less-avid AChEi detoxification.

14 ine regulatory mechanisms restraining energy-avid adaptive immunity in times of starvation and exerti

15 CT for the detection of unexpected (18)F-FDG-avid additional primary malignant tumors in patients bei

16 Seventy-one patients with (18)F-FDG-avid adenocarcinoma of the pancreas before treatment wer

17 assed residues 1167 to 1193 of SspB promoted avid adherence of P. gingivalis, whereas a peptide deriv

18 -tg mice was virtually absent in contrast to avid adhesion in WT mice.

19 pendent of actin rearrangement necessary for avid adhesion.

20 he mixed-pattern lesions remained [(18)F]FDG avid after treatment.

21 rates SLAM with repeat masking tools and the AVID alignment program to allow for rapid alignment and

22 We have developed a new tumor-avid amino acid, 1-amino-3-fluorocyclobutane-1-carboxyli

23 unctional parameters-number of (11)C-acetate-avid and (18)F-FDG-avid focal bone lesions and (11)C-ace

24 ntiated thyroid cancers are typically iodine-avid and can be effectively treated with radioiodine.

25 that oxidation of 13C-octanoate in brain is avid and contributes approximately 20% to total brain ox

26 G negative, but 12 (48%) remained [(18)F]FDG avid and increased in size on CT.

27 cers, some gastric cancers are not (18)F-FDG-avid and its clinical value is still debatable.

28 assays, but responder animals showed a more avid and persistent IFN-gamma response.

29 ximal regions usually correspond to sites of avid and persistent sister chromatid cohesion mediated b

30 eighted signal intensity in five women, more avid and rapid contrast enhancement in five, and early c

31 l) to maximally increase brain uptake of the avid and selective P-gp substrate (11)C-N-desmethyl-lope

32 istant cells that are unresponsive to highly avid and specific melanoma-reactive CTLs, despite mainta

33 ll cell lung cancer is fluorodeoxy-D-glucose avid and that positron emission tomography has potential

34 ould further be improved by using more tumor-avid and/or target-specific photosensitizers.

35 ha- and beta-chains of the TCR from a highly avid anti-gp100 CTL clone were isolated and used to cons

36 MS2-3C8 binds MBP-DR4 as tightly as the most avid anti-microbial TCRs.

37 Highly avid anti-tumour lymphocytes can be isolated from immuni

38 ytes was confirmed in comparison with highly avid antimelanoma lymphocytes by the high levels of cyto

39 motherapy followed by the transfer of highly avid antitumor lymphocytes can mediate significant tumor

40 Early identification of infants with avid appetites may make it possible to implement strateg

41 r the three GST isozymes, results suggesting avid associations between GST and 15-d-PGJ(2) or 15-d-PG

42 Binding may be considerably less avid at physiological albumin concentrations than previo

43 ation reverses strong learned revulsion into avid attraction.

44 xillary nodal metastases, (18)F-fluciclovine-avid axillary nodes were seen in 20.

45 The most avid binder, a pentamer, binds the rCUG repeat hairpin w

46 ective, relatively permeable to calcium, and avid binders of alpha-bungarotoxin.

47 Both NOXA and Bim are avid binders of Mcl-1, but a functional linkage between

48 p80 UIMs positions the domains for efficient avid binding across a single K63 linkage, thus defining

49 e not effective in clinical trials, but more avid binding agents may be.

50 of delivery vectors by humoral immunity, and avid binding between enzyme and its DNA target will prom

51 oncomitant blockage of multiple epitopes and avid binding by fusing multiple (different) monovalent N

52 the O-antigen-deficient mutant in regard to avid binding by murine complement C3 or resistance to se

53 ealed structural insights into the nature of avid binding by the BhCBM6/56 pair and how the orientati

54 gregate into a configuration compatible with avid binding by these multivalent ligands.

55 an interactions are typically very weak, and avid binding is achieved when proteins express multiple

56 o high streptavidin density, suggesting that avid binding may require engagement of more than four tr

57 st clearance and low hepatic background, the avid binding of 99mTc-duramycin to the infarcted myocard

58 The avid binding of AID to ssDNA could result from its large

59 We report avid binding of LPA to the receptor for advanced glycati

60 The avid binding of SAP displaces H1-type histones and there

61 l activity of CD4-BFFI is most likely due to avid binding of the bivalent FI peptides as well as the

62 The avid binding of tissue inhibitors of metalloproteinases

63 The avid binding of USF1/2 heterodimers to these E-boxes occ

64 h1 epitopes in highly conserved regions with avid binding to class II molecules.

65 By exploiting its avid binding to microtubules, we have now devised a meth

66 t this enhancement is a direct result of its avid binding to the coactivator CREB binding protein (CB

67 y connected VHS and UIM motifs of ESCRT-0 in avid binding to the polyubiquitin chain.

68 Among these, avid binding was detected to a single defined glycan, Ne

69 None of the TFOs tested showed avid binding when C residues were in position 11, althou

70 e(32), and Cys(44)) in R(CE) are crucial for avid binding with AKAP(CE), whereas side chains from Leu

71 binding to sialosides, the D151G NA exhibits avid binding with broad specificity toward alpha2-3 sial

72 te corresponded to elevated HA synthesis and avid BMEC adhesion.

73 uptake (TLF10) and total volume of fluoride avid bone metastases (FTV10).

74 y mass and lymph nodes and shows several PET-avid bone metastases.

75 ors and those within the hypermetabolic, PET-avid brain were falsely negative.

76 IM to Lys(63)-linked diubiquitin is not only avid, but also cooperative.

77 of focal lesions (FLs), especially when FDG-avid by PET-computed tomography, was positively linked t

78 eractions of C17.2 NSCs with host axons, the avid C17.2 cell-host axon contacts, and the ensheathing

79 Neither effect could be elicited by a more avid CaM-binding peptide, suggesting that generalized Ca

80 neral recombinases, is shown here to have an avid capability to make DNA joints between homologous DN

81 e arrangement of capsid subunits and enables avid capsid binding.

82 CVN potently blocks HIV entry through highly avid carbohydrate-mediated interactions with the HIV-env

83 m poorly, but the GES-5 beta-lactamase is an avid catalyst for turnover of this antibiotic.

84 ls is due to a greater fraction of (18)F-FLT-avid cells rather than a change in (18)F-FLT uptake by i

85 At 20% serum, a subpopulation of (18)F-FLT-avid cells, representing 61% of the total population, em

86 lculated for the primary tumor and (18)F-FLT-avid cervical lymph nodes for all scans.

87 DIALIGN for local alignment and compared to AVID, ClustalW, DIALIGN and LAGAN for global alignment.

88 s over 70% identity over 100 bp) compared to AVID, ClustalW, DIALIGN and LAGAN.

89 BRAF mutation was associated with (18)F-FDG-avid CNS disease (P = 0.0357), higher SUVmax (P = 0.0044

90 between fluorine 18 fluorodeoxyglucose (FDG)-avid colonic lesions and immunohistochemical assay findi

91 amino acids, were found to produce the most avid competitors.

92 to DNA binding, as the clamp loader forms an avid complex with beta at a 5' site.

93 indicating that both are required to make an avid complex.

94 demonstrate that several types of cancer are avid consumers of acetate, which facilitates macromolecu

95 As(III) species, by avid coordination to the cysteine residues of unfolded r

96 While the avid dieter obsesses about reduction of different body p

97 with thyroid cancer and in patients with RAI-avid diffuse bilateral pulmonary metastases, even when r

98 female sex, subtotal thyroidectomy, and RAI-avid diffuse bilateral pulmonary metastases.

99 sk of PET/CT revealing unsuspected (18)F-FDG-avid distant metastases in stage III IDC patients was 2.

100 nagement of thyroid cancer patients with RAI-avid distant metastases.

101 nagement of thyroid cancer patients with RAI-avid distant metastases.

102 The present study includes patients who had AVID-eligible arrhythmias, both randomized and not rando

103 h) mortality similar to that of higher-risk, AVID-eligible VAs.

104 In murine cultures, avid erythrophagocytosis is triggered by transduction of

105 PET studies showed rapid blood clearance and avid extraction of (18)F-FTO and of (18)F-FTP into the h

106 ulocytosis that was partially compensated by avid extramedullary erythropoiesis at all erythroid stag

107 The presence of more than 3 FDG-avid FLs, related to fundamental features of myeloma bio

108 s-number of (11)C-acetate-avid and (18)F-FDG-avid focal bone lesions and (11)C-acetate general marrow

109 Bilateral hilar (18)F-FDG-avid foci are often noted on PET studies of patients wit

110 lues (SUV max), purity (absence of (18)F-FDG-avid foci in nonhilar mediastinal nodes), symmetry (diff

111 ith the finding of bilateral hilar (18)F-FDG-avid foci underwent a staging-only PET study; 52 scans f

112 Metastatic PSMA-avid foci were also visualized with (68)Ga-THP-PSMA PET.

113 Metastases avid for (89)Zr-trastuzumab by PET/CT were biopsied and

114 The binding of Nef was similarly avid for native HLA-I and recombinant HLA-I A2 at the PM

115 , many classes of brain tumors are generally avid for transferrin.

116 This avid formation of promoter complexes requires both linka

117 atment-naive patient the emergence of highly avid, gamma interferon-secreting, CD8(+) CTL recognizing

118 F-FDG is a well-established method using the avid glucose uptake of tumor cells.

119 Transferred PBMC contained highly avid, gp100:209-217 peptide-reactive CD8(+) T cells.

120 To facilitate their avid growth and proliferation, cancer cells not only alt

121 ovalent bond formation was not necessary for avid GST-nitroalkene interactions.

122 The O(2)-avid hemoglobin from the parasitic nematode Ascaris suum

123 tures of the active site in the extremely O2-avid hemoglobin from the trematode Paramphistomum epicli

124 t underwent biopsy and RF ablation of an FDG-avid hepatic focus.

125 ells blockade of calcium currents results in avid high-frequency bursting, consistent with the notion

126 ET-CT will be used to assess response in FDG-avid histologies using the 5-point scale.

127 because degenerative changes are not choline-avid; however, the agent may accumulate in recent trauma

128 99mTc-Glucarate is an infarct-avid imaging agent with the potential for very early det

129 c-Glucarate ((99m)Tc-GLA) is a novel infarct-avid imaging agent.

130 follow-up had fluorine 18 fluorodeoxyglucose-avid IMLN, with a median standardized uptake value of 2.

131 Only one of the 12 of the fluorodeoxyglucose-avid IMLNs was malignant, with a PPV of 0.083 (95% CI: 0

132 They simply express TCRs that are less avid in their binding to KdHA.

133 r, 12 (86%; 95% CI, 67%-100%) were (18)F-FDG-avid, including all those 10 mm or greater (mean standar

134 arbocation intermediate, suggesting that the avid inhibition by R- and S-azabisabolenes arises more f

135 ent a model in which this region mediates an avid interaction between MHC A and paramyosin in paralle

136 ull-length ARRDC3 and Nedd4 is driven by the avid interaction of both PPXY motifs with either the WW2

137 with binding kinetics that suggest a highly avid interaction toward virion-associated envelope.

138 lls with anti-CD3 mAb; however, a direct and avid interaction with T cells does not appear to be nece

139 nd conformational variability may facilitate avid interactions with diverse substrates.

140 All patients exhibited (123)I-MIBG-avid, International Neuroblastoma Staging System stage 4

141 the protein and the ferric siderophore is so avid (Kd < 0.2 nM) that FepA tolerated the large reducti

142 er, these data indicate that HCELL is a more avid L-selectin ligand than PSGL-1 and may be the prefer

143 B2.7 transfectants to adhere to laminin, but avid laminin binding depends on coexpression of VLA-6.

144 e shown to be improved luminescent tags with avid lanthanide binding and up to 3-fold greater lumines

145 sion, proliferation, collagen synthesis, and avid LDL metabolism.

146 zed to lean body mass, of the most (18)F-FDG-avid lesion (PERCIST 1) and by the change in the sum of

147 (18)F-FLT-avid lesions ( approximately 2/patient) were segmented o

148 18% (95% CI: 5%, 64%) for patients with FDG-avid lesions (P < .0001).

149 35% (95% CI: 20%, 61%) for patients with FDG-avid lesions (P = .014).

150 ithout implants but with confirmed (18)F-FDG-avid lesions adjacent to common implant locations.

151 y counted the number of suggestive (18)F-FDG-avid lesions and provided the TNM staging for the 5 pati

152 th aggressive lymphomas, the presence of FDG-avid lesions at PET/CT performed before allogeneic and a

153 portion of SPECT/CT demonstrated non-iodine-avid lesions in 32 of 148 patients.

154 nificance of [(18)F]fluorodeoxyglucose (FDG)-avid lesions in patients with lymphoma treated with stem

155 ficant effect on small, moderately (18)F-FDG-avid lesions near the implant site that possibly may go

156 (18)F-FDG-avid lesions not only were found in impinged spinal nerv

157 I], 2.3-28.3; P = .0008), fluorodeoxyglucose-avid lesions on baseline positron emission tomography (H

158 splantation patients rarely demonstrated FDG-avid lesions suggestive of disease without malignant pat

159 PET/CT examinations were evaluated for FDG-avid lesions suggestive of disease.

160 -cell transplantation recipients, 50 had FDG-avid lesions suggestive of lymphoma, defined as FDG-avid

161 ILC patients were upstaged by non-(18)F-FDG-avid lesions visible only on the CT images.

162 zed uptake value (SUV) of the most (18)F-FDG-avid lesions was recorded.

163 Two hundred twenty-seven tracer-avid lesions were identified in 50 patients.

164 ogeneic SCT, 23 of 73 patients (32%) had FDG-avid lesions, and before autologous SCT, 11 of 102 patie

165 % (95% CI: 64%, 82%) in patients without FDG-avid lesions, but only 18% (95% CI: 5%, 64%) for patient

166 rval [CI]: 56%, 82%) in patients without FDG-avid lesions, but only 35% (95% CI: 20%, 61%) for patien

167 On larger, highly (18)F-FDG-avid lesions, the metallic implants had only a limited e

168 logous SCT, 11 of 102 patients (11%) had FDG-avid lesions.

169 d standardized uptake value (SUV) in focally avid lesions.

170 des was comparable with patients without FDG-avid lesions.

171 Avid ligation of a PKC isoform is a previously unappreci

172 There was avid localization of ICG to the focal lesions at all tim

173 tation of patients with lymphoma, benign FDG-avid </= 1.5 cm lymph nodes can mimic malignancy.

174 Disease-free survival of patients with FDG-avid </= 1.5 cm lymph nodes was comparable with patients

175 he dosimetry of thyroid cancer patients with avid lung metastases that exhibit prolonged retention in

176 vent lung toxicity in the presence of iodine-avid lung metastases.

177 In 21 of 22 patients with FDG-avid lymph nodes </= 1.5 cm, biopsy attempts were benign

178 c stem-cell transplantation demonstrated FDG-avid lymph nodes up to 1.5 cm in short axis on PET/CT, w

179 In 1 of 6 patients, (18)F-FDG-avid lymph nodes were not identified as pathologic on CT

180 ponse assessment for [18F]fluorodeoxyglucose-avid lymphomas in clinical practice and late-phase trial

181 y incorporated into standard staging for FDG-avid lymphomas.

182 tometric analyses, using highly specific and avid mAbs to probe permeabilized whole blood leukocytes,

183 AVID maintained a Registry on all patients, randomized o

184 a-labeled prostate-specific membrane antigen-avid malignancies were rare (0.7%) in PC patients; atypi

185 se and development of new sites of (18)F-FDG-avid malignancy.

186 helpful when fluorine 18 fluorodeoxyglucose-avid masses that are not seen sufficiently with nonenhan

187 EM PSF was seen in cases of mildly (18)F-FDG-avid mediastinal nodes in lung cancer and small liver me

188 ry tumour site plus meta-iodobenzylguanidine avid metastases present before myeloablative therapy, fo

189 A total of 67 choline-avid metastases were identified: 44 bone lesions and 23

190 For (18)F-FDG-avid metastases, the relative risk of PET/CT revealing u

191 All 20 demonstrated (18)F-FDG-avid metastases.

192 -fluorodeoxyglucose at detecting non-glucose-avid metastatic lesions.

193 trospectively analyzed 352 patients with RAI-avid metastatic well-differentiated TC treated with (131

194 trospectively analyzed 352 patients with RAI-avid metastatic well-differentiated TC treated with (131

195 we have identified a peptide with projected avid MHC-binding activity that elicited immunoreactivity

196 ly used measures of evolutionary constraint (AVID, MLAGAN, SLAGAN, phastCons, WebMCS) demonstrate tha

197 merization with FHR2 and FHR5 generates more avid molecules that very effectively compete with FH bin

198 alpha- and beta-chain of a TCR from a highly avid murine CTL clone that recognized the human p53(264-

199 However, avid myocardial glucose uptake may preclude its use for

200 ts with the nephrotic syndrome is limited by avid Na(+) reabsorption by the terminal nephron.

201 d tomography (PET-CT) imaging of macrophages-avid nanoparticles detects rejection of heart allografts

202 e have synthesized a library of GRP receptor-avid nanoplatforms by conjugating gold nanoparticles (Au

203 ated with pTR, in 82 patients with (18)F-FDG-avid nodes before NAC we observed mNR in 10 (12.2%) not

204 d higher sensitivity than MR imaging for FDG-avid nodules (95.6% vs 80.0%, P = .008).

205 gly recommend investigation of all (18)F-FDG-avid nodules 1 cm or larger with ultrasound and fine-nee

206 ave high sensitivity in the detection of FDG-avid nodules and nodules 0.5 cm in diameter or larger, w

207 ing was 70.3% for all nodules, 95.6% for FDG-avid nodules, and 88.6% for nodules 0.5 cm in diameter o

208 A total of 69 nodules, including 45 FDG-avid nodules, were detected with PET/CT.

209 e detection of small, non-fluorodeoxyglucose-avid nodules.

210 rger, with low sensitivity for small non-FDG-avid nodules.

211 t surface expression is limited by the least avid of the two glutamate binding sites.

212 tastatic osteosarcoma or skeletal metastases avid on bone scan were treated with 1, 3, 4.5, 6, 12, 19

213 Of the 25 [(18)F]FDG-avid osteoblastic lesions, 13 (52%) became [(18)F]FDG ne

214 erroportin expression, illustrated by a more avid oxidation of extracellular low-density lipoprotein

215 nd its putative radiometabolite 11C-dLop are avid P-gp substrates.

216 PET studies in normal rats demonstrated an avid pancreas uptake of (18)F-FP-(+)-DTBZ.

217 as imaged using a radiolabeled, somatostatin-avid peptide (P829).

218 The galectin-3-avid peptide G3-C12 (ANTPCGPYTHDCPVKR) was synthesized w

219 rgeting and SPECT properties of a galectin-3-avid peptide identified from bacteriophage display were

220 e dyes to somatostatin and bombesin receptor-avid peptides and examined their receptor binding affini

221 an array of inflammatory stimuli but retain avid phagocytic and bacteriocidal activity.

222 und in a Jurkat mutant with a constitutively avid phenotype, J+hi1.19 or the wild-type Jn.9 genomic o

223 Avid plasma protein binding of UCN-01, as measured durin

224 for measuring the brightness using antibody-avid polystyrene beads and flow cytometry.

225 One hundred nineteen patients with (18)F-FDG-avid primary malignancies underwent a single-injection,

226 dy PET/CT detected new, unexpected (18)F-FDG-avid primary malignant tumors in at least 1.2% of patien

227 rred for a PET/CT-guided biopsy of (18)F-FDG-avid primary or metastatic lesions in different location

228 or the alignment comparisons, as well as the AVID program, are publicly available.

229 cortical thinning and multiple bilateral PET-avid pulmonary nodules, with the largest in the left upp

230 The use of tracer-avid radiopharmaceuticals and handheld, intraoperative,

231 Avid Radiopharmaceuticals, Banner Alzheimer's Foundation

232 /CT) with a glucagon-like peptide-1 receptor avid radiotracer, and compare detection rates with conve

233 4) retained picomolar functional potency and avid receptor binding properties.

234 outcomes were observed among patients in the AVID registry and the main trial.

235 study participation but were followed in the AVID registry.

236 e a regulatory program of slow induction and avid repression, and a fitness detriment during the gluc

237 rotein composition is currently a subject of avid research aimed at determining both fundamental prop

238 t difference in the PFS of patients with PET-avid residual disease in one site versus multiple sites

239 ymptoms, mild anemia is well tolerated by an avid runner.

240 es recruited to the intestinal mucosa retain avid scavenger and host defense functions but acquire pr

241 but different, i.e., slower, for the Oncyte-Avid slide.

242 uted biomolecules was observed on the Oncyte-Avid slide.

243 m albumin (BSA) on FAST, Unisart, and Oncyte-Avid slides and compared the spot morphology of the inkj

244 ew, suggesting that dominant individuals are avid social learners, whereas subordinates focus on lear

245 Sodium appetite is an instinct that involves avid specific intention.

246 mIBG scans from 280 patients with mIBG-avid, stage 4 neuroblastoma enrolled on the Children's O

247 ed and ICD-treated patients entered into the AVID study (patients presenting with sustained ventricul

248 e survived an episode of cardiac arrest, the AVID study conclusively established the superiority of t

249 The AVID Study was a multicenter, randomized comparison of d

250 rhythmics Versus Implantable Defibrillators (AVID) Study compared treatment with implantable cardiove

251 rhythmics Versus Implantable Defibrillators (AVID) study demonstrated improved survival in patients w

252 rhythmics Versus Implantable Defibrillators (AVID) Study Registry to determine how the location of ve

253 The derivatized peptide is an avid substrate and is suitable for use with biological s

254 ese enzymes, in some systems Ca(II) promotes avid substrate binding and sequence discrimination.

255 11C-Loperamide is an avid substrate for P-glycoprotein (P-gp), but it is rapi

256 bstantial blockade to increase the uptake of avid substrates, blunting the ability of investigators t

257 ffinity sink during selections, and a highly avid target for subsequent immunoassay capture.

258 and three intraoperative biopsies of 36 FDG-avid targets between November 2007 and August 2010.

259 pose that inducing expression of this highly avid TCR in patient PBMC has the potential to induce tum

260 actin cytoskeleton, suggesting selection for avid TCR microclusters.

261 ontrary to pathogenic T cells, Tregs require avid TCR-ligand interaction to undergo thymic developmen

262 utated DTCs are significantly more (18)F-FDG-avid than BRAF-WT tumors.

263 d binding in the sensor gel is slightly less avid than in solution.

264 liberately unfolded VL was dramatically more avid than that of folded VL, mimicking the interaction i

265 ics Versus Implantable Defibrillators Study (AVID), the Canadian Implantable Defibrillator Study (CID

266 ed uptake value (SUV) was calculated for FDG-avid thyroid foci.

267 (18)F-FDG-avid thyroid incidentaloma (TI) is seen in approximately

268 considered before investigation of (18)F-FDG-avid TI and certainly before aggressive treatment.

269 Overall survival with (18)F-FDG-avid TI was poor because of the prognosis associated wit

270 nician decision not to investigate (18)F-FDG-avid TI were all predictors of mortality, with hazard ra

271 in a large cohort of patients with (18)F-FDG-avid TI with long-term follow-up to assess the validity

272 ultiple gp120s simultaneously, and is highly avid toward gp120, we could remove its capacity to enhan

273 ed by radionuclide imaging of the neutrophil-avid tracer 99mTcRP517 and tissue myeloperoxidase activi

274 hiosemicarbazone) (copper-ATSM) is a hypoxia-avid tracer for the selective identification of hypoxic

275 dy, we sent patients who participated in the AVID trial a questionnaire, to be completed anonymously,

276 g within 3 months after randomization in the AVID trial, 78 percent within 6 months, and 88 percent w

277 rhythmics versus Implantable Defibrillators (AVID) trial compared antiarrhythmic-drug therapy with th

278 rhythmics Versus Implantable Defibrillators (AVID) trial identified patients with both stable and uns

279 rhythmics Versus Implantable Defibrillators (AVID) trial through December 31, 1996 was assessed using

280 rhythmics Versus Implantable Defibrillators (AVID) trial, patients with a correctable cause of an ele

281 responses to furosemide (possibly reflecting avid tubular oxygen consumption) are associated with les

282 pting RT-escalated radiation dose to the FDG-avid tumor detected by midtreatment PET provided a favor

283 RT can target high-dose radiation to the FDG-avid tumor on midtreatment FDG-PET to improve local tumo

284 /CT image analysis and total (68)Ga-DOTATATE-Avid tumor volume ((68)Ga-DOTATATE TV) was determined.

285 Nine posttherapy WBS showed iodine-avid tumor, of which 4 also had positive (124)I PET/CT f

286 e, 59 years; range, 35-87 years) with 29 FDG-avid tumors (median size, 1.4 cm; range, 0.6-4.4 cm) wer

287 Small, non-avid tumors and those within the hypermetabolic, PET-avi

288 pathologic parameters that allowed (18)F-FDG-avid tumors to be detected with a sensitivity of 85% and

289 All (18)F-FDG-avid tumors were delineated with an 50% threshold of SUV

290 used primarily in the setting of non-iodine-avid tumors.

291 ection of potentially cancerous, radiotracer-avid tumors.

292 and should not be confused with (99m)Tc-MIBI-avid-tumors.

293 n homeostasis in animals is a consequence of avid uptake and retention, except during conditions of l

294 An avid uptake of (18)F-TFB was observed in human NIS (hNIS

295 Sensitive AMLs showed more avid uptake of arginine from the extracellular environme

296 by neutrophils was observed, in contrast to avid uptake of IgA complexes.

297 small intestinal villi with the capacity for avid uptake of Salmonella and Yersinia organisms and flu

298 density lipoprotein (LDL) can result in the avid uptake of these lipoproteins via a family of macrop

299 See Web Site References section for AVID Web address and Web addresses for other programs di

300 also performed a quantitative comparison of AVID with other popular alignment tools.